1443 related articles for article (PubMed ID: 33547281)
1. Structure and binding properties of Pangolin-CoV spike glycoprotein inform the evolution of SARS-CoV-2.
Wrobel AG; Benton DJ; Xu P; Calder LJ; Borg A; Roustan C; Martin SR; Rosenthal PB; Skehel JJ; Gamblin SJ
Nat Commun; 2021 Feb; 12(1):837. PubMed ID: 33547281
[TBL] [Abstract][Full Text] [Related]
2. Bat and pangolin coronavirus spike glycoprotein structures provide insights into SARS-CoV-2 evolution.
Zhang S; Qiao S; Yu J; Zeng J; Shan S; Tian L; Lan J; Zhang L; Wang X
Nat Commun; 2021 Mar; 12(1):1607. PubMed ID: 33707453
[TBL] [Abstract][Full Text] [Related]
3. Molecular basis of cross-species ACE2 interactions with SARS-CoV-2-like viruses of pangolin origin.
Niu S; Wang J; Bai B; Wu L; Zheng A; Chen Q; Du P; Han P; Zhang Y; Jia Y; Qiao C; Qi J; Tian WX; Wang HW; Wang Q; Gao GF
EMBO J; 2021 Aug; 40(16):e107786. PubMed ID: 34018203
[TBL] [Abstract][Full Text] [Related]
4. Untangling the Evolution of the Receptor-Binding Motif of SARS-CoV-2.
Delaye L; Román-Padilla L
J Mol Evol; 2024 Jun; 92(3):329-337. PubMed ID: 38777906
[TBL] [Abstract][Full Text] [Related]
5. Molecular evolution and phylogenetic analysis of SARS-CoV-2 and hosts ACE2 protein suggest Malayan pangolin as intermediary host.
Lopes LR; de Mattos Cardillo G; Paiva PB
Braz J Microbiol; 2020 Dec; 51(4):1593-1599. PubMed ID: 32592038
[TBL] [Abstract][Full Text] [Related]
6. An update on the origin of SARS-CoV-2: Despite closest identity, bat (RaTG13) and pangolin derived coronaviruses varied in the critical binding site and O-linked glycan residues.
Malaiyan J; Arumugam S; Mohan K; Gomathi Radhakrishnan G
J Med Virol; 2021 Jan; 93(1):499-505. PubMed ID: 32633815
[TBL] [Abstract][Full Text] [Related]
7. V367F Mutation in SARS-CoV-2 Spike RBD Emerging during the Early Transmission Phase Enhances Viral Infectivity through Increased Human ACE2 Receptor Binding Affinity.
Ou J; Zhou Z; Dai R; Zhang J; Zhao S; Wu X; Lan W; Ren Y; Cui L; Lan Q; Lu L; Seto D; Chodosh J; Wu J; Zhang G; Zhang Q
J Virol; 2021 Jul; 95(16):e0061721. PubMed ID: 34105996
[TBL] [Abstract][Full Text] [Related]
8. Cross-Neutralization of SARS-CoV-2-Specific Antibodies in Convalescent and Immunized Human Sera against the Bat and Pangolin Coronaviruses.
Srisutthisamphan K; Saenboonrueng J; Wanitchang A; Viriyakitkosol R; Jongkaewwattana A
Viruses; 2022 Aug; 14(8):. PubMed ID: 36016415
[TBL] [Abstract][Full Text] [Related]
9. SARS-CoV-2 and bat RaTG13 spike glycoprotein structures inform on virus evolution and furin-cleavage effects.
Wrobel AG; Benton DJ; Xu P; Roustan C; Martin SR; Rosenthal PB; Skehel JJ; Gamblin SJ
Nat Struct Mol Biol; 2020 Aug; 27(8):763-767. PubMed ID: 32647346
[TBL] [Abstract][Full Text] [Related]
10. SARS-CoV-2's claimed natural origin is undermined by issues with genome sequences of its relative strains: Coronavirus sequences RaTG13, MP789 and RmYN02 raise multiple questions to be critically addressed by the scientific community.
Deigin Y; Segreto R
Bioessays; 2021 Jul; 43(7):e2100015. PubMed ID: 34046923
[TBL] [Abstract][Full Text] [Related]
11. Effect of SARS-CoV-2 B.1.1.7 mutations on spike protein structure and function.
Yang TJ; Yu PY; Chang YC; Liang KH; Tso HC; Ho MR; Chen WY; Lin HT; Wu HC; Hsu SD
Nat Struct Mol Biol; 2021 Sep; 28(9):731-739. PubMed ID: 34385690
[TBL] [Abstract][Full Text] [Related]
12. Molecular simulation studies of the interactions between the human/pangolin/cat/bat ACE2 and the receptor binding domain of the SARS-CoV-2 spike protein.
Ma S; Li H; Yang J; Yu K
Biochimie; 2021 Aug; 187():1-13. PubMed ID: 33984400
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein Binding to ACE2 Receptors from Human, Pets, Farm Animals, and Putative Intermediate Hosts.
Zhai X; Sun J; Yan Z; Zhang J; Zhao J; Zhao Z; Gao Q; He WT; Veit M; Su S
J Virol; 2020 Jul; 94(15):. PubMed ID: 32404529
[TBL] [Abstract][Full Text] [Related]
14. Evolution of the SARS-CoV-2 spike protein in the human host.
Wrobel AG; Benton DJ; Roustan C; Borg A; Hussain S; Martin SR; Rosenthal PB; Skehel JJ; Gamblin SJ
Nat Commun; 2022 Mar; 13(1):1178. PubMed ID: 35246509
[TBL] [Abstract][Full Text] [Related]
15. The genetic structure of SARS-CoV-2 does not rule out a laboratory origin: SARS-COV-2 chimeric structure and furin cleavage site might be the result of genetic manipulation.
Segreto R; Deigin Y
Bioessays; 2021 Mar; 43(3):e2000240. PubMed ID: 33200842
[TBL] [Abstract][Full Text] [Related]
16. SARS-CoV-2 D614G spike mutation increases entry efficiency with enhanced ACE2-binding affinity.
Ozono S; Zhang Y; Ode H; Sano K; Tan TS; Imai K; Miyoshi K; Kishigami S; Ueno T; Iwatani Y; Suzuki T; Tokunaga K
Nat Commun; 2021 Feb; 12(1):848. PubMed ID: 33558493
[TBL] [Abstract][Full Text] [Related]
17. Cryo-electron microscopy structures of the N501Y SARS-CoV-2 spike protein in complex with ACE2 and 2 potent neutralizing antibodies.
Zhu X; Mannar D; Srivastava SS; Berezuk AM; Demers JP; Saville JW; Leopold K; Li W; Dimitrov DS; Tuttle KS; Zhou S; Chittori S; Subramaniam S
PLoS Biol; 2021 Apr; 19(4):e3001237. PubMed ID: 33914735
[TBL] [Abstract][Full Text] [Related]
18. Broad and Differential Animal Angiotensin-Converting Enzyme 2 Receptor Usage by SARS-CoV-2.
Zhao X; Chen D; Szabla R; Zheng M; Li G; Du P; Zheng S; Li X; Song C; Li R; Guo JT; Junop M; Zeng H; Lin H
J Virol; 2020 Aug; 94(18):. PubMed ID: 32661139
[TBL] [Abstract][Full Text] [Related]
19. Effects of common mutations in the SARS-CoV-2 Spike RBD and its ligand, the human ACE2 receptor on binding affinity and kinetics.
Barton MI; MacGowan SA; Kutuzov MA; Dushek O; Barton GJ; van der Merwe PA
Elife; 2021 Aug; 10():. PubMed ID: 34435953
[TBL] [Abstract][Full Text] [Related]
20. SARS-CoV-2, the pandemic coronavirus: Molecular and structural insights.
Kadam SB; Sukhramani GS; Bishnoi P; Pable AA; Barvkar VT
J Basic Microbiol; 2021 Mar; 61(3):180-202. PubMed ID: 33460172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
